Determination of intracellular calcium inhibition effect and cytotoxocity of engineered Bradykinin antagonists.
Chronic pain is a physiological issue universally associated with many medical conditions, severe injuries and major surgeries. Bradykinin (BK) and kallidin (KD) are short-term peptidic mediators that double as potent endogenous pain inducers. Jointly known as kinins, their releases occur during tis...
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Final Year Project (FYP) |
| Language: | English |
| Published: |
2013
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/10356/53682 |